MFDS — authorised 28 May 2021
- Marketing authorisation holder: ALKERMES INC
- Status: likely_approved
🇰🇷 Lybalvi in South Korea
MFDS authorised Lybalvi on 28 May 2021
Marketing authorisation
Lybalvi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Lybalvi approved in South Korea?
Yes. MFDS authorised it on 28 May 2021.
Who is the marketing authorisation holder for Lybalvi in South Korea?
ALKERMES INC holds the South Korean marketing authorisation.